Class II Recall

Chiesi USA, Inc.

Product
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
Reason
Lack of Assurance of Sterility
Classification
Class II
Status
Ongoing
Lot
Lot #: 1239521, 1237454, Exp. Date 10/2027
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Chiesi USA, Inc. — Class II Recall | MedicineWatch US